雅培Abbott Laboratories (ABT) 2017年年度报告「NYSE」.pdf

1、ABBOTT 2017 ANNUAL REPORT2017 ANNUAL REPORTABBOTT.COM1009764ab_cvr.indd13/2/1810:36 AMPlease carefully do a final review of art and text to insure correctness and accuracy.Digital color representation may not be accurate,use actual Pantone color specifications.After clients final approval is receive

2、d,SandyAlexanderis not responsible for errors or legal compliance.Any changes made after receipt of clients final approval of art and text is clients responsibility.Die lines and call-outs exist on individual layers to be removed prior to processing.Customer Name:Date:Operator:CSR:Job Number:File Na

3、me:Page Size:File URL:200 Entin Road|Clifton,NewJersey 07014|p 973.470.8100|f 973.470.9269|02-Mar-1802-Mar-181009764ab_cvr_1_T1009764ab_cvr_1_T LasserKaren LasserAbbott Labs_1552Abbott Labs_1552CMYKzfold17.1875 X 11.000017.1875 X 11.0000TABLE OF CONTENTS1Letter to Shareholders5This is Abbott10Diabet

4、es Care12Cardiac Rhythm Management14Heart Failure16Structural Heart and Vascular Care18Neuromodulation20Established Pharmaceuticals22Nutrition26Diagnostics31Abbott FutureAbbott is a global healthcare company whose diversebusinesses help people live fuller lives through betterhealth.We keep hearts he

5、althy,nourish bodies at everystage of life,help people feel and move better,and provideinformation,medicines,and breakthrough technologiesto manage peoples health.With growing businessesin both developed and developing economies offeringmarket-leading products that align with long-termdemographic an

6、d technological trends,we are creatinglong-term shareholder value by delivering consistentgrowth,strong cash flow,and steadily increasing returns.Since 2015,Gabrielle hasrelied on the revolutionarytechnology in AbbottsFreeStyle Libre system tomonitor her glucose levels.on the cover:GABRIELLE WEMPEFr